Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
IV Infusion to Oral Dosing: Conversion Methods01:28

IV Infusion to Oral Dosing: Conversion Methods

The development of extended-release formulations has facilitated the transition from intravenous to oral medication, offering a more convenient and patient-friendly approach to drug administration. This transition, however, requires careful management to ensure that therapeutic drug levels are maintained, preserving efficacy and avoiding adverse effects. Understanding pharmacokinetic principles and dosage calculations is critical during this process.Pharmacokinetics of the...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of Processing and Stabilizer Selection on Microstructure, Stability and Rheology of Emulsion-Based Semisolid Formulations.

Pharmaceutics·2025
Same author

Synergistic Computational and Experimental Investigation of Covalent Organic Frameworks for Efficient Alcohol Dehydration.

ACS applied materials & interfaces·2025
Same author

The seventh blind test of crystal structure prediction: structure ranking methods.

Acta crystallographica Section B, Structural science, crystal engineering and materials·2024
Same author

The seventh blind test of crystal structure prediction: structure generation methods.

Acta crystallographica Section B, Structural science, crystal engineering and materials·2024
Same author

An Exceptionally Salt Tolerant Copoly(Maleimide Sulfobetaine) - Structural Requirements for Ultra-Salt Tolerance.

Macromolecular rapid communications·2024
Same author

Evaluation of polymer-preservative interactions for preservation efficacy: molecular dynamics simulation and QSAR approaches.

Nanoscale·2024

Related Experiment Video

Updated: Jun 1, 2026

Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis
09:26

Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis

Published on: November 17, 2011

Theophylline-gentisic acid (1/1).

Srinivasulu Aitipamula, Pui Shan Chow, Reginald B H Tan

    Acta Crystallographica. Section E, Structure Reports Online
    |May 18, 2011
    PubMed
    Summary
    This summary is machine-generated.

    This study details a novel cocrystal formed by the anti-asthma drug theophylline and the anti-inflammatory drug gentisic acid. This pharmaceutical cocrystal, involving two active ingredients, presents an unexplored area in drug development.

    Related Experiment Videos

    Last Updated: Jun 1, 2026

    Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis
    09:26

    Cellular Lipid Extraction for Targeted Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry Analysis

    Published on: November 17, 2011

    Area of Science:

    • Crystallography
    • Pharmaceutical Science
    • Materials Science

    Background:

    • Theophylline is an anti-asthmatic drug, and gentisic acid is a non-steroidal anti-inflammatory drug.
    • Pharmaceutical cocrystals are crystalline solids composed of two or more different molecules in a defined stoichiometric ratio.
    • Cocrystals involving two active pharmaceutical ingredients (APIs) are relatively unexplored.

    Purpose of the Study:

    • To synthesize and characterize a novel 1:1 cocrystal of theophylline and gentisic acid.
    • To investigate the crystal structure and intermolecular interactions within the cocrystal.
    • To explore the potential of dual-API cocrystals in pharmaceutical applications.

    Main Methods:

    • Cocrystallization of theophylline and gentisic acid.
    • Single-crystal X-ray diffraction analysis to determine the crystal structure.
    • Analysis of hydrogen bonding and π-π stacking interactions.

    Main Results:

    • A 1:1 cocrystal of theophylline (C7H8N4O2) and gentisic acid (C7H6O4) was successfully formed.
    • The crystal structure revealed two-dimensional hydrogen-bonded sheets stabilized by N-H⋯O and O-H⋯N interactions.
    • Significant π-π stacking interactions were observed between the purine and benzoic acid rings, with a centroid-centroid distance of 3.348(1) Å.

    Conclusions:

    • The formation of a dual-API cocrystal between theophylline and gentisic acid demonstrates a viable strategy for creating new pharmaceutical forms.
    • The characterized hydrogen bonding and π-π stacking interactions are crucial for the stability of this cocrystal.
    • This work highlights the potential of exploring dual-API cocrystals as a novel area in pharmaceutical research and development.